George Sellers
Stock Analyst at Stephens & Co.
(1.31)
# 3,576
Out of 4,964 analysts
43
Total ratings
27.27%
Success rate
-7.09%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $41.33 | +64.53% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $126.22 | +129.76% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $35.89 | +61.60% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $116.73 | +52.50% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $9.23 | +160.02% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $30.59 | +135.37% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $2.00 | +150.00% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $7.40 | +237.84% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $27.40 | +108.03% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $96.56 | -26.47% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $41.33
Upside: +64.53%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $126.22
Upside: +129.76%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $35.89
Upside: +61.60%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $116.73
Upside: +52.50%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $9.23
Upside: +160.02%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $30.59
Upside: +135.37%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $2.00
Upside: +150.00%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $7.40
Upside: +237.84%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $27.40
Upside: +108.03%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $96.56
Upside: -26.47%